Hermes J Florez

Professor

  • 2963 Citations
19952019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Hermes J Florez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Veterans Medicine & Life Sciences
Metformin Medicine & Life Sciences
Life Style Medicine & Life Sciences
Hispanic Americans Medicine & Life Sciences
Obesity Medicine & Life Sciences
Cardiovascular Diseases Medicine & Life Sciences
Population Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2007

GENERAL CLINICAL RESEARCH CENTER

Alejandro, R., Saab, P., Weiss, S. M., Antoni, M. H., Feaster, D. J., Florez, H. J., Schneiderman, N., Hurwitz, B., Clarkson, J., Goldberg, R., Penedo, F., Elsas, L., Goldschmidt-Clermont, P., Ramsey, R. E., Scott, G. B., Levis, S., Berkovitz, G. D., Miguez, M., Haslett, P. A. J., Sipski, M., Marks, J., Goodkin, K., Ramsay, E., Jayaraman, S., Hoffman, R. W., Duara, S., Bandstra, E. S., Nash, M. S. & Scott, G. B.

National Institutes of Health

8/15/029/30/07

Project: Research project

Research Output 1995 2019

  • 2963 Citations
  • 82 Article
  • 4 Review article
  • 2 Chapter
  • 1 Comment/debate
56 Citations (Scopus)

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

REWIND Investigators, Jul 13 2019, In : The Lancet. 394, 10193, p. 121-130 10 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Randomized Controlled Trials
Placebos
Cardiovascular Diseases
Incidence
14 Citations (Scopus)

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

REWIND Investigators, Jul 13 2019, In : The Lancet. 394, 10193, p. 131-138 8 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Randomized Controlled Trials
Placebos
Glomerular Filtration Rate
Kidney

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680

Ritzel, R., Harris, S. B., Baron, H., Florez, H. J., Roussel, R., Espinasse, M., Muehlen-Bartmer, I., Zhang, N., Bertolini, M., Brulle-Wohlhueter, C., Munshi, M. & Bolli, G. B., Aug 1 2019, In : Diabetes care. 42, 8, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Safety
Insulin Glargine
2 Citations (Scopus)

Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort

VA Million Veteran Program, Jun 25 2019, In : Women's Health Issues. 29, p. S56-S66

Research output: Contribution to journalArticle

Veterans
gender-specific factors
Demography
Health
health
5 Citations (Scopus)

Long-term weight loss with metformin or lifestyle intervention in the Diabetes prevention Program outcomes study

Diabetes Prevention Program Research Group, Jan 1 2019, In : Annals of internal medicine. 170, 10, p. 682-690 9 p.

Research output: Contribution to journalArticle

Metformin
Life Style
Weight Loss
Outcome Assessment (Health Care)
Weights and Measures